Meprocompren

Meprocompren Brand names, Meprocompren Analogs

Meprocompren Brand Names Mixture

No information avaliable

Meprocompren Chemical_Formula

C₂₀H₂₃NS

Meprocompren RX_link

No information avaliable

Meprocompren fda sheet

Meprocompren msds (material safety sheet)

Meprocompren Synthesis Reference

No information avaliable

Meprocompren Molecular Weight

309.469 g/mol

Meprocompren Melting Point

< 25 ^oC

Meprocompren H₂O Solubility

Soluble as HCl salt

Meprocompren State

Liquid

Meprocompren LogP

5.7

Meprocompren Dosage Forms

Tablets (oral, 1 mg)

Meprocompren Indication

Used for the symptomatic treatment of parkinsonism.

Meprocompren Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprocompren Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprocompren side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprocompren Patient Information

Meprocompren Organisms Affected

Humans and other mammals